Showing results (1241-1250 of 1,255) with videos related to

Sort By:
Pageof 126
Hypertension (Dallas, Tex. : 1979)|February 22, 2018
Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment)Eduardo M Krieger, Luciano F Drager, Dante M A Giorgi, et al.
Eclinicalmedicine|September 6, 2021
Effects of Selenium treatment on cardiac function in Chagas heart disease: Results from the STCC randomized TrialMarcelo T Holanda, Mauro F F Mediano, Alejandro M Hasslocher-Moreno, et al.
The European Respiratory Journal|March 25, 2014
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statementChristoph Lange, Ibrahim Abubakar, Jan-Willem C Alffenaar, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 2, 2025
Drug management of TB in the intensive care setting: an international multicentre studyS Tiberi, O Akkerman, G Sotgiu, et al.
The Lancet. Microbe|December 22, 2024
Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant dataPuck T Pelzer, Logan Stuck, Leonardo Martinez, et al.
Atherosclerosis|October 1, 2008
Association of lipoprotein lipase D9N polymorphism with myocardial infarction in type 2 diabetes: the genetics, outcomes, and lipids in type 2 diabetes (GOLD) studyMaria C Izar, Tatiana Helfenstein, Silvia S Ihara, et al.
BMJ (Clinical Research Ed.)|January 21, 2021
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trialViviane C Veiga, João A G G Prats, Danielle L C Farias, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 30, 2022
Clinical standards for drug-susceptible pulmonary TBO W Akkerman, R Duarte, S Tiberi, et al.
The Lancet. Global Health|August 12, 2022
Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysisLeonardo Martinez, Olivia Cords, Qiao Liu, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 2, 2022
Clinical standards for the dosing and management of TB drugsJ W C Alffenaar, S L Stocker, L Davies Forsman, et al.
Pageof 126